Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,958,728
+$4,273,547 QoQ
Shares Held
647,679
+24.2% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#39
of 330 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Derivatives in NTLA

reported options exposure · as of Jun 30, 2026
CallValue
$18,227,916
CallShares
1,077,300
PutValue
$7,267,140
PutShares
429,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. NTLA ranks #27 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in NTLA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,267,140 429,500
2026-06-30 $18,227,916 1,077,300
2026-06-30 $10,958,728 647,679
2026-03-31 $21,381,196 1,667,800
2026-03-31 $6,685,181 521,465
2026-03-31 $6,581,788 513,400
2025-12-31 $6,291,202 699,800
2025-12-31 $5,471,898 608,665
2025-12-31 $5,213,301 579,900
2025-09-30 $15,376,534 890,361
2025-09-30 $5,346,792 309,600
2025-09-30 $7,714,509 446,700
2025-06-30 $7,166,141 763,981
2025-06-30 $1,479,226 157,700
2025-06-30 $2,155,524 229,800
2025-03-31 $3,050,936 429,105
2025-03-31 $1,129,779 158,900
2025-03-31 $638,478 89,800
2024-12-31 $3,936,416 337,600
2024-12-31 $6,152,049 527,620
2024-12-31 $855,844 73,400
2024-09-30 $8,078,205 393,100
2024-09-30 $8,570,398 417,051
2024-09-30 $1,839,225 89,500
2024-06-30 $6,644,622 296,900
2024-06-30 $4,937,878 220,638
2024-06-30 $8,817,720 394,000
2024-03-31 $6,932,520 252,000
2024-03-31 $7,050,813 256,300
2024-03-31 $2,737,905 99,524
2023-12-31 $5,960,764 195,499
2023-12-31 $10,150,121 332,900
2023-12-31 $7,244,424 237,600
2023-09-30 $3,358,044 106,200
2023-09-30 $3,108,246 98,300
2023-09-30 $3,408,288 107,789
2023-06-30 $8,060,085 197,648
2023-06-30 $4,612,218 113,100
2023-06-30 $11,414,322 279,900
2023-03-31 $5,352,046 143,602
2023-03-31 $4,066,157 109,100
2023-03-31 $5,061,266 135,800
2022-12-31 $4,748,529 136,100
2022-12-31 $4,335,256 124,255
2022-12-31 $3,234,303 92,700
2022-09-30 $11,678,852 208,700
2022-09-30 $6,442,450 115,126
2022-09-30 $8,097,412 144,700
2022-06-30 $6,708,096 129,600
2022-06-30 $4,792,976 92,600